Please wait a minute...
文章检索
预防医学  2026, Vol. 38 Issue (9): 886-889,894    DOI: 10.19485/j.cnki.issn2096-5087.2026.09.005
  论著 本期目录 | 过刊浏览 | 高级检索 |
初治成功肺结核患者复发的影响因素分析
张若娣, 杨利, 滕楠, 陈腾伟, 许圆圆
台州市疾病预防控制中心(台州市卫生监督所),浙江 台州 318000
Influencing factors for recurrence of pulmonary tuberculosis among patients with initial treatment success
ZHANG Ruodi, YANG Li, TENG Nan, CHEN Tengwei, XU Yuanyuan
Taizhou Center for Disease Control and Prevention (Taizhou Institute of Public Health Supervision),Taizhou, Zhejiang 318000, China
全文: PDF(890 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 分析初治成功肺结核患者复发的影响因素,为预防肺结核复发提供依据。方法 选择2010—2024年浙江省台州市确诊且初治成功的肺结核患者为研究对象,通过中国疾病预防控制信息系统结核病管理信息系统收集基本信息、合并症和病原学结果等资料。采用回顾性队列研究方法,以初治成功结束日期为观察起点,2025年为观察终点,肺结核复发(初治成功结束≥6个月后再次确诊肺结核)为结局事件,采用多因素Cox比例风险回归模型分析初治成功肺结核患者复发的影响因素。结果 纳入初治成功肺结核患者37 236例,其中男性25 879例,占69.50%;女性11 357例,占30.50%。年龄为(46.09±19.34)岁。随访时间M(QR)为7.85(7.75)年,肺结核复发873例,复发率为2.34%。多因素Cox比例风险回归分析结果显示,与女性相比,男性初治成功肺结核患者复发风险升高32.2%(HR=1.322,95%CI:1.129~1.548);年龄每增加1岁,初治成功肺结核患者复发风险升高1.6%(HR=1.016,95%CI:1.012~1.020);与农民相比,职业为工人和学生的初治成功肺结核患者复发风险分别降低27.5%(HR=0.725,95%CI:0.587~0.895)和51.0%(HR=0.490,95%CI:0.265~0.908);与病原学阴性/无结果相比,病原学阳性的初治成功肺结核患者复发风险升高60.1%(HR=1.601,95%CI:1.396~1.835)。结论 初治成功肺结核患者复发可能与性别、年龄、职业和病原学结果有关。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
张若娣
杨利
滕楠
陈腾伟
许圆圆
关键词 : 肺结核,  复发,  影响因素,  病原学阳性    
Abstract:Objective To analyze the recurrence and influencing factors of pulmonary tuberculosis among patients with initial treatment success, so as to provide evidence for preventing pulmonary tuberculosis recurrence. Methods Patients with initial treatment success for pulmonary tuberculosis confirmed in Taizhou City, Zhejiang Province from 2010 to 2024 were selected as study subjects. Data including basic information, comorbidities and etiological results were collected through the Tuberculosis Management Information System of China Disease Prevention and Control Information System. A retrospective cohort study was conducted. The end date of initial treatment success was set as the starting point of observation, and 2025 was set as the end point of observation. Pulmonary tuberculosis recurrence (re-diagnosis of pulmonary tuberculosis ≥6 months after the completion of initial treatment success) was set as the outcome event. A multivariable Cox proportional hazards regression model was used to analyze the influencing factors for recurrence of pulmonary tuberculosis among patients with initial treatment success. Results A total of 37 236 patients with initial treatment success for pulmonary tuberculosis were enrolled, including 25 879 males (69.50%) and 11 357 females (30.50%). The mean age of patients was (46.09±19.34) years. The median follow-up duration was 7.85 (interquartile range, 7.75) years. A total of 873 recurrence cases were identified, with a recurrence rate of 2.34%. Multivariable Cox proportional hazards regression analysis showed that male patients had a 32.2% (HR=1.322, 95%CI: 1.129-1.548) higher recurrence risk than female patients. Each one-year increase in age was associated with a 1.6% (HR=1.016, 95%CI: 1.012-1.020) higher recurrence risk. Compared with farmers, workers and students had 27.5% (HR=0.725, 95%CI: 0.587-0.895) and 51.0% (HR=0.490, 95%CI: 0.265-0.908) lower recurrence risk, respectively. Patients with positive etiology had a 60.1% (HR=1.601, 95%CI: 1.396-1.835) higher recurrence risk than those with negative or missing etiology. Conclusion Gender, age, occupation and etiological results were possibly associated with recurrence of pulmonary tuberculosis among patients with initial treatment success.
Key words: pulmonary tuberculosis    recurrence    influencing factor    positive etiology
收稿日期: 2026-05-27      修回日期: 2026-08-25     
中图分类号:  R521  
作者简介: 张若娣,硕士,医师,主要从事结核病防治工作
通信作者: 许圆圆,E-mail:shangyuxuyuanyuan@126.com   
引用本文:   
张若娣, 杨利, 滕楠, 陈腾伟, 许圆圆. 初治成功肺结核患者复发的影响因素分析[J]. 预防医学, 2026, 38(9): 886-889,894.
ZHANG Ruodi, YANG Li, TENG Nan, CHEN Tengwei, XU Yuanyuan. Influencing factors for recurrence of pulmonary tuberculosis among patients with initial treatment success. Preventive Medicine, 2026, 38(9): 886-889,894.
链接本文:  
https://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2026.09.005      或      https://www.zjyfyxzz.com/CN/Y2026/V38/I9/886
[1] 李涛,赵雁林,贾忠伟.结核病复发及其影响因素研究进展[J].疾病监测,2024,39(4):403-411.
[2] Li T,Zhang B,Du X,et al.Recurrent pulmonary tuberculosis in China,2005 to 2021[J/OL].JAMA Netw Open,2024,7(8)[2026-08-25].http://doi.org/10.1001/jamanetworkopen.2024.27266.
[3] 常玥,章亚夫,许圆圆,等.浙江台州肺结核流行特征分析(2011—2021年)[J].国际流行病学传染病学杂志,2023,50(5):353-356.
[4] 杨利,常玥,林海江.2016—2021年台州市肺结核流行特征分析[J].预防医学,2022,34(11):1150-1155.
[5] Hu Y D,Wang M,Gao Y,et al.Epidemiological analysis and risk factors of recurrent pulmonary tuberculosis in western Zhejiang Province,China(2007-2024)[J/OL].Front Public Health,2026,14[2026-08-25].http://doi.org/10.3389/fpubh.2026.1777279.
[6] WS 288—2017 肺结核诊断[S].
[7] WS 196—2017 结核病分类[S].
[8] 中国疾病预防控制中心结核病预防控制中心.中国结核病防治工作技术考核手册[M].北京:人民卫生出版社,2021.
[9] 姜游力,张培泽,邓国防,等.结核病患者诊断延迟及其影响因素研究进展[J].结核与肺部疾病杂志,2021,2(3):289-293.
[10] 王荣,许可,洪忻,等.南京市初治肺结核患者成功治疗后复发及影响因素分析[J].中国热带医学,2022,22(8):735-738,752.
[11] 张红伟,陈曦,孙闪华,等.北京市初治肺结核患者治疗成功后复发情况及危险因素分析[J].疾病监测,2021,36(8):818-823.
[12] 孙晴,王小平,符剑,等.2013—2020年江苏省南通市初治结核病患者成功治疗后复发情况及其影响因素分析[J].疾病监测,2024,39(10):1270-1275.
[13] 严天心,马文斌,王嘉,等.2010—2023年中国肺结核合并症患者治疗依从性及治疗结局影响因素分析[J].中国防痨杂志,2025,47(10):1268-1278.
[14] Gebrie E,Baynes H W,Mulugeta B,et al.Sex hormones and tuberculosis:implications for immune regulation,susceptibility,and disease pathogenesis[J/OL].Tuberculosis(Edinb),2026,157[2026-08-25].http://doi.org/10.1016/j.tube.2026.102740.
[15] 周旭,王巧智,万燕萍,等.衡阳市成功治疗的肺结核患者5年复发影响因素分析[J].预防医学,2022,34(3):268-271.
[16] 陈松华,张钰,刘魁,等.新发肺结核病患者成功治疗后发病重新登记情况的跟踪研究[J].疾病监测,2023,38(11):1301-1306.
[17] 黄珊珊,董小伟,周芳静,等.广东省肺结核患者复发流行特征及其影响因素分析[J].中国防痨杂志,2026,48(1):41-48.
[18] Jiang H,Yin J F,Liu F C,et al.Epidemiology of recurrent pulmonary tuberculosis by bacteriological features of 100 million residents in China[J/OL].BMC Infect Dis,2022,22(1)[2026-08-25].http://doi.org/10.1186/s12879-022-07622-w.
[1] 王晴晴, 刘泓, 张伟, 王红彩, 李旭鸿, 王一诺, 张媛媛. 老年肺癌化疗患者社会衰弱及影响因素分析[J]. 预防医学, 2026, 38(9): 917-922.
[2] 李建云, 吴颖涵, 杨云娟, 戴琳纾, 李慧瑜, 魏依蕾. 云南省中小学生伤害发生的横断面研究[J]. 预防医学, 2026, 38(9): 865-869.
[3] 黄文, 祝彩琴, 黄敏钢, 许璐璐, 陈康康, 王柯颖, 陈国江, 陈奇峰. 绍兴市老年人跌倒的现况调查[J]. 预防医学, 2026, 38(9): 875-879.
[4] 王馨婧, 丁焕, 张琪, 高嵩, 许祝平. 2005—2024年无锡市肺结核发病趋势及年龄-时期-队列分析[J]. 预防医学, 2026, 38(9): 890-894.
[5] 孙靓, 刘影, 戴威, 张婷, 薛锦锋, 苏凤华. 东城区医务人员干眼症的横断面研究[J]. 预防医学, 2026, 38(9): 945-949.
[6] 王红林, 赵丽, 邓峰. 宝鸡市成年居民超重肥胖的流行现状及影响因素[J]. 预防医学, 2026, 38(8): 785-789.
[7] 卢烨, 余红. 青少年特发性脊柱侧凸发病机制和影响因素研究进展[J]. 预防医学, 2026, 38(8): 794-799.
[8] 沈新秀, 周权, 雷静, 戴思芸, 肖春, 林仲. 中老年糖尿病患者视网膜病变的影响因素分析[J]. 预防医学, 2026, 38(8): 800-804.
[9] 刘露, 卢辉, 王苹芳, 覃云鹏, 吴晓倩, 刘波, 张稳, 李澳, 冯鸿燕. 2016—2024年张家界市肺结核时空聚集性分析[J]. 预防医学, 2026, 38(8): 819-823.
[10] 袁芳, 张爱平. 江北区居民高血压、糖尿病和血脂异常共病现状及影响因素研究[J]. 预防医学, 2026, 38(8): 815-818,823.
[11] 张慧慧, 赵娥, 孙高峰, 张明东, 糜建雄. 乌鲁木齐市居民高血压与糖尿病共病现况调查[J]. 预防医学, 2026, 38(7): 652-656.
[12] 熊燕, 夏岚, 李运葵, 钟引, 王丹霞, 李婷. 四川省肺结核患者密切接触者筛查结果分析[J]. 预防医学, 2026, 38(7): 666-670.
[13] 赵玲慧, 凌洁, 徐漪, 曹敏忆. 嘉兴市社区老年人痴呆现况调查[J]. 预防医学, 2026, 38(7): 671-674.
[14] 江学奇, 陈同, 林相, 车洋, 林律, 桑国鑫, 王奕楠, 张栋梁. 宁波市肺结核患者确诊延迟分析[J]. 预防医学, 2026, 38(7): 699-702.
[15] 马宗康, 叶锦, 樊娇, 蔡美怡, 齐韵菡, 陈凤辉. 老年高血压住院患者主动健康行为的潜在剖面分析[J]. 预防医学, 2026, 38(7): 680-685.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed